Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
K-CREATE: H. pylori Eradication Duration and Tailored Therapy
NCT04147065Phase 4Recruiting
- Sponsor
- Incheon St. Mary's Hospital
- Start
- Jul 2021
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of clarithromycin, amoxicillin, tetracycline, metronidazole, bismuth subsalicylate in Helicobacter pylori infection, sponsored by Incheon St. Mary's Hospital. Started Jul 2021; status: recruiting.
02
Drugs
clarithromycinamoxicillintetracyclinemetronidazolebismuth subsalicylate
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT04147065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04147065.